[Testicular lymphoma in a 72-year-old patient]

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by 'Rete Ematologica Pugliese'.

Annals of hematology·2022

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.

International journal of cancer·2019

Recovering from chronic myeloid leukemia: the patients' perspective seen through the lens of narrative medicine.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2017

Live concerts reduce cancer inpatients' anxiety.

European journal of cancer care·2016

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

The use of MYD88 and IGH polymerase chain reaction in the diagnosis and follow-up of Bing-Neel syndrome.

Haematologica·2026

CD19 antigen: from tumor target to safety switch in CAR-T cell therapy.

Haematologica·2026

Adult-onset activated PI3Kδ syndrome presenting with HLH-like hyperinflammation, autoimmunity, and thrombosis: an underrecognized inborn error of immunity.

Haematologica·2026

Divergent roles of interleukin-12p40 and interleukin-18 in severe fibrosing chronic graft-versus-host-disease, immunity, and post-transplant outcomes.

Haematologica·2026

Response to comment on: "Ligature-induced periodontitis promotes Dnmt3aR878H-driven clonal hematopoiesis".

Haematologica·2026

Optimizing exposure: the case for dose-dense CAR T-cell administration.

Haematologica·2026

Concurrent Kaposi Sarcoma and B-cell Lymphoma in an HIV-Negative Patient: A Case Report.

Cureus·2026

A Tumor-Microenvironment-Responsive Chemically Masked IL‑2 Prodrug Potentiates PD‑1 Checkpoint Blockade and Elicits Robust Antitumor Efficacy.

ACS central science·2026

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers.

Frontiers in immunology·2026

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.

Frontiers in oncology·2026

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

BMC medicine·2026

Imaging features of soft tissue hibernoma: a review of 73 cases.

Skeletal radiology·2026

Related Experiment Videos

[Testicular lymphoma in a 72-year-old patient]

Related Concept Videos

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by 'Rete Ematologica Pugliese'.

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial.

Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.

Recovering from chronic myeloid leukemia: the patients' perspective seen through the lens of narrative medicine.

Live concerts reduce cancer inpatients' anxiety.

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.

The use of MYD88 and IGH polymerase chain reaction in the diagnosis and follow-up of Bing-Neel syndrome.

CD19 antigen: from tumor target to safety switch in CAR-T cell therapy.

Adult-onset activated PI3Kδ syndrome presenting with HLH-like hyperinflammation, autoimmunity, and thrombosis: an underrecognized inborn error of immunity.

Divergent roles of interleukin-12p40 and interleukin-18 in severe fibrosing chronic graft-versus-host-disease, immunity, and post-transplant outcomes.

Response to comment on: "Ligature-induced periodontitis promotes Dnmt3aR878H-driven clonal hematopoiesis".

Optimizing exposure: the case for dose-dense CAR T-cell administration.

Concurrent Kaposi Sarcoma and B-cell Lymphoma in an HIV-Negative Patient: A Case Report.

A Tumor-Microenvironment-Responsive Chemically Masked IL‑2 Prodrug Potentiates PD‑1 Checkpoint Blockade and Elicits Robust Antitumor Efficacy.

Nanotechnology-enabled immunomodulation in esophageal cancer: targeting the tumor microenvironment to overcome therapeutic barriers.

Interpretation of p53 immunohistochemical stain of TP53-mutated myeloid neoplasms.

miR-155-5p drives coordinated tumor and macrophage reprogramming across multiple cancer entities.

Imaging features of soft tissue hibernoma: a review of 73 cases.

Related Experiment Videos

[Testicular lymphoma in a 72-year-old patient]

Related Concept Videos

Related Articles